Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity.
D000818:Animals; D001058:Apomorphine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D003000:Clonidine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D002818:Cordotomy; D003342:Corpus Striatum / Q000502:physiology; D004298:Dopamine / Q000032:analysis / Q000378:metabolism*; D004338:Drug Combinations; D004357:Drug Synergism; D006801:Humans; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism*; D010643:Phenoxybenzamine / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D012018:Reflex / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D013116:Spinal Cord / Q000032:analysis / Q000378:metabolism / Q000502:physiology; D013239:Stereotyped Behavior / Q000187:drug effects; D013268:Stimulation, Chemical
D004338:Drug Combinations; D008781:Methyltyrosines; D011941:Receptors, Adrenergic; D010643:Phenoxybenzamine; D012110:Reserpine; D011433:Propranolol; D003000:Clonidine; D001058:Apomorphine; D004298:Dopamine; D009638:Norepinephrine; D010646:Phentolamine